Tyvaso: Medgend

Tyvaso FDA Approved Drugs

REMODULIN [Treprostinil^{C₂₃H₃₄O₅}]

10mg/ml (iv (infusion), subcutaneous injectable)

1mg/ml (iv (infusion), subcutaneous injectable)

2.5mg/ml (iv (infusion), subcutaneous injectable)

United Therap^{May 21, 2002}

Administration of remodulin diluted for intravenous infusion with sterile diluent for flolan or sterile diluent for epoprostenol sodium prior to administration.
Administration of remodulin diluted for intravenous infusion with sterile water for injection or 0.9% sodium chloride injection prior to administration.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

TYVASO [Treprostinil^{C₂₃H₃₄O₅}]

0.6mg/ml (inhalation solution)

United Therap^{Jul 30, 2009}

Method of treating pulmonary hypertension by administering treprostinil or a salt thereof by inhalation using a device.
Treatment of pulmonary hypertension by inhalation.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.